ArticleDermatology and therapy2025

Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.

Miguel Mansilla-Polo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.